Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Chronic Renal Failure

  Free Subscription


Articles published in Kidney Int

Retrieve available abstracts of 165 articles:
HTML format
Text format



Single Articles


    June 2019

  1. Wyatt CM, Drueke TB. High-dose IV iron for anemia correction in chronic kidney disease. Kidney Int. 2019;95:727-730.
    Kidney Int. 2019;95:1518.
    PubMed     Text format    


  2. RAPHAEL KL
    The Dietary Approaches to Stop Hypertension (DASH) diet in chronic kidney disease: should we embrace it?
    Kidney Int. 2019;95:1296-1298.
    PubMed     Text format     Abstract available


    May 2019
  3. CHEUNG AK, Chang TI, Cushman WC, Furth SL, et al
    Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2019;95:1027-1036.
    PubMed     Text format     Abstract available


  4. MAZZAFERRO S, Pasquali M
    Direct bone effects of calcimimetics in chronic kidney disease?
    Kidney Int. 2019;95:1012-1014.
    PubMed     Text format     Abstract available


    April 2019
  5. HOUSE AA, Wanner C, Sarnak MJ, Pina IL, et al
    Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2019 Apr 30. pii: S0085-2538(19)30276.
    PubMed     Text format     Abstract available


  6. CHAN CT, Blankestijn PJ, Dember LM, Gallieni M, et al
    Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2019 Apr 12. pii: S0085-2538(19)30138.
    PubMed     Text format     Abstract available


  7. JEONG JH, Biruete A, Tomayko EJ, Wu PT, et al
    Results from the randomized controlled IHOPE trial suggest no effects of oral protein supplementation and exercise training on physical function in hemodialysis patients.
    Kidney Int. 2019 Apr 2. pii: S0085-2538(19)30389.
    PubMed     Text format     Abstract available


  8. JADOUL M, Bieber BA, Martin P, Akiba T, et al
    Prevalence, incidence, and risk factors for hepatitis C virus infection in hemodialysis patients.
    Kidney Int. 2019;95:939-947.
    PubMed     Text format     Abstract available


  9. ROSSIGNOL P, Frimat L, Zannad F
    The safety of mineralocorticoid antagonists in maintenance hemodialysis patients: two steps forward.
    Kidney Int. 2019;95:747-749.
    PubMed     Text format     Abstract available


  10. HE H, Li B, Gao X, Li H, et al
    A dialysis patient with isolated persistent left superior vena cava.
    Kidney Int. 2019;95:1000.
    PubMed     Text format    


  11. FORMAN C, Sran H, Wafi A
    Delayed stricture of irradiated iliac arteries after renal transplantation mimicking transplant renal artery stenosis.
    Kidney Int. 2019;95:999.
    PubMed     Text format    



  12. Caplin B, Yang C-W, Anand S, et al., on behalf of International Society of Nephrology's International Consortium of Collaborators on Chronic Kidney Disease of Unknown Etiology (i3C). The International Society of Nephrology's International Consortium o
    Kidney Int. 2019;95:997-998.
    PubMed     Text format    


  13. LANDAU SI, Guo X, Velazquez H, Torres R, et al
    Regulated necrosis and failed repair in cisplatin-induced chronic kidney disease.
    Kidney Int. 2019;95:797-814.
    PubMed     Text format     Abstract available


  14. WYATT CM, Drueke TB
    High-dose IV iron for anemia correction in chronic kidney disease.
    Kidney Int. 2019;95:727-730.
    PubMed     Text format    


  15. SINGH G, Swamy A, Kumari K, Brijwal M, et al
    The Case | Mass in nonfunctioning first renal allograft in a recipient of 2 transplant kidneys.
    Kidney Int. 2019;95:1001-1002.
    PubMed     Text format    


    March 2019
  16. MANERA KE, Tong A, Craig JC, Shen J, et al
    An international Delphi survey helped develop consensus-based core outcome domains for trials in peritoneal dialysis.
    Kidney Int. 2019 Mar 29. pii: S0085-2538(19)30340.
    PubMed     Text format     Abstract available


  17. MAYER GJ, Wanner C, Weir MR, Inzucchi SE, et al
    Analysis from the EMPA-REG OUTCOME((R)) trial indicates empagliflozin may assist in preventing the progression of chronic kidney disease in patients with type 2 diabetes irrespective of medications that alter intrarenal hemodynamics.
    Kidney Int. 2019 Mar 21. pii: S0085-2538(19)30317.
    PubMed     Text format     Abstract available


  18. AZUKAITIS K, Ju W, Kirchner M, Nair V, et al
    Low levels of urinary epidermal growth factor predict chronic kidney disease progression in children.
    Kidney Int. 2019 Mar 20. pii: S0085-2538(19)30184.
    PubMed     Text format     Abstract available


  19. BALLY L, Gubler P, Thabit H, Hartnell S, et al
    Fully closed-loop insulin delivery improves glucose control of inpatients with type 2 diabetes receiving hemodialysis.
    Kidney Int. 2019 Mar 20. pii: S0085-2538(19)30322.
    PubMed     Text format     Abstract available


  20. FU R, Kim SJ, de Oliveira C, Coyte PC, et al
    An instrumental variable approach quantifies and confirms the duration of pre-transplant dialysis has negative impact on kidney transplant recipient survival.
    Kidney Int. 2019 Mar 19. pii: S0085-2538(19)30323.
    PubMed     Text format     Abstract available


  21. OTTLEWSKI I, Munch J, Wagner T, Schonauer R, et al
    Value of renal gene panel diagnostics in adults waiting for kidney transplantation due to undetermined end-stage renal disease.
    Kidney Int. 2019 Mar 15. pii: S0085-2538(19)30187.
    PubMed     Text format     Abstract available


  22. SCHLACKOW I, Kent S, Herrington W, Emberson J, et al
    Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease.
    Kidney Int. 2019 Mar 12. pii: S0085-2538(19)30171.
    PubMed     Text format     Abstract available


  23. ROSSING P, Persson F, Frimodt-Moller M
    Improvements in albuminuria and chronic kidney disease progression with the appetite suppressant lorcaserin.
    Kidney Int. 2019 Mar 7. pii: S0085-2538(19)30281.
    PubMed     Text format    


  24. ROWE C, Sitch AJ, Barratt J, Brettell EA, et al
    Biological variation of measured and estimated glomerular filtration rate in patients with chronic kidney disease.
    Kidney Int. 2019 Mar 7. pii: S0085-2538(19)30274.
    PubMed     Text format     Abstract available


  25. BAI M, Chen H, Ding D, Song R, et al
    MicroRNA-214 promotes chronic kidney disease by disrupting mitochondrial oxidative phosphorylation.
    Kidney Int. 2019 Mar 5. pii: S0085-2538(19)30114.
    PubMed     Text format     Abstract available


  26. LOUTRADIS C, Sarafidis PA, Ekart R, Papadopoulos C, et al
    The effect of dry-weight reduction guided by lung ultrasound on ambulatory blood pressure in hemodialysis patients: a randomized controlled trial.
    Kidney Int. 2019 Mar 5. pii: S0085-2538(19)30270.
    PubMed     Text format     Abstract available


  27. AGARWAL AK, Haddad NJ, Vachharajani TJ, Asif A, et al
    Innovations in vascular access for hemodialysis.
    Kidney Int. 2019 Mar 4. pii: S0085-2538(19)30103.
    PubMed     Text format     Abstract available


  28. MULAY SR
    Multifactorial functions of the inflammasome component NLRP3 in pathogenesis of chronic kidney diseases.
    Kidney Int. 2019 Mar 4. pii: S0085-2538(19)30109.
    PubMed     Text format     Abstract available


  29. BANERJEE T, Crews DC, Tuot DS, Pavkov ME, et al
    Poor accordance to a DASH dietary pattern is associated with higher risk of ESRD among adults with moderate chronic kidney disease and hypertension.
    Kidney Int. 2019 Mar 4. pii: S0085-2538(19)30113.
    PubMed     Text format     Abstract available


  30. COMBALIA A, Munoz-Mahamud E, Cofan F
    Giant calcified mass in a hemodialysis patient.
    Kidney Int. 2019;95:719.
    PubMed     Text format    


  31. CHAMARTHI G, Koratala A
    Embedded peritoneal dialysis catheter.
    Kidney Int. 2019;95:718.
    PubMed     Text format    


  32. GORAYA N, Simoni J, Sager LN, Madias NE, et al
    Urine citrate excretion as a marker of acid retention in patients with chronic kidney disease without overt metabolic acidosis.
    Kidney Int. 2019 Mar 1. pii: S0085-2538(18)30945.
    PubMed     Text format     Abstract available


    February 2019
  33. SANCHIS P, Ho CY, Liu Y, Beltran LE, et al
    Arterial "inflammaging" drives vascular calcification in children on dialysis.
    Kidney Int. 2019 Feb 28. pii: S0085-2538(19)30035.
    PubMed     Text format     Abstract available


  34. XU H, Kuja-Halkola R, Chen X, Magnusson PKE, et al
    Higher body mass index is associated with incident diabetes and chronic kidney disease independent of genetic confounding.
    Kidney Int. 2019 Feb 27. pii: S0085-2538(19)30047.
    PubMed     Text format     Abstract available


  35. KIKUCHI K, Hamano T, Wada A, Nakai S, et al
    Predilution online hemodiafiltration is associated with improved survival compared with hemodialysis.
    Kidney Int. 2019 Feb 16. pii: S0085-2538(18)30897.
    PubMed     Text format     Abstract available


  36. CONNAUGHTON DM, Kennedy C, Shril S, Mann N, et al
    Monogenic causes of chronic kidney disease in adults.
    Kidney Int. 2019 Feb 12. pii: S0085-2538(18)30839.
    PubMed     Text format     Abstract available


  37. TANASIYCHUK T, Kushnir DA, Antebi A, Frajewicki V, et al
    Paradoxically normal location of peritoneal dialysis catheter.
    Kidney Int. 2019;95:470.
    PubMed     Text format    


  38. EVENEPOEL P, Claes K, Cavalier E, Meijers B, et al
    A distinct bone phenotype in ADPKD patients with end-stage renal disease.
    Kidney Int. 2019;95:412-419.
    PubMed     Text format     Abstract available


  39. CANAUD B, Kooman J, Selby NM, Taal M, et al
    Sodium and water handling during hemodialysis: new pathophysiologic insights and management approaches for improving outcomes in end-stage kidney disease.
    Kidney Int. 2019;95:296-309.
    PubMed     Text format     Abstract available


    January 2019
  40. HAMMER F, Malzahn U, Donhauser J, Betz C, et al
    A randomized controlled trial of the effect of spironolactone on left ventricular mass in hemodialysis patients.
    Kidney Int. 2019 Jan 29. pii: S0085-2538(18)30906.
    PubMed     Text format     Abstract available


  41. CONNOLLY R, Denton MD, Humphreys H, McLoughlin RM, et al
    Would hemodialysis patients benefit from a Staphylococcus aureus vaccine?
    Kidney Int. 2019 Jan 26. pii: S0085-2538(18)30824.
    PubMed     Text format     Abstract available


  42. VIECELLI AK, Lok CE
    Hemodialysis vascular access in the elderly-getting it right.
    Kidney Int. 2019;95:38-49.
    PubMed     Text format     Abstract available


  43. SMITH SF, Hosgood SA, Nicholson ML
    Ischemia-reperfusion injury in renal transplantation: 3 key signaling pathways in tubular epithelial cells.
    Kidney Int. 2019;95:50-56.
    PubMed     Text format     Abstract available


  44. CAPLIN B, Yang CW, Anand S, Levin A, et al
    The International Society of Nephrology's International Consortium of Collaborators on Chronic Kidney Disease of Unknown Etiology: report of the working group on approaches to population-level detection strategies and recommendations for a minimum dat
    Kidney Int. 2019;95:4-10.
    PubMed     Text format    


  45. CHEN Z, Zhang W, Chen X, Hsu CY, et al
    Trends in end-stage kidney disease in Shanghai, China.
    Kidney Int. 2019;95:232.
    PubMed     Text format    


  46. WANG J, Zhang L, Zhao MH
    The authors reply.
    Kidney Int. 2019;95:233.
    PubMed     Text format    


    December 2018
  47. VERZOLA D, Barisione C, Picciotto D, Garibotto G, et al
    Emerging role of myostatin and its inhibition in the setting of chronic kidney disease.
    Kidney Int. 2018 Dec 28. pii: S0085-2538(18)30777.
    PubMed     Text format     Abstract available


  48. WHITLOCK RH, Leslie WD, Shaw J, Rigatto C, et al
    The Fracture Risk Assessment Tool (FRAX(R)) predicts fracture risk in patients with chronic kidney disease.
    Kidney Int. 2018 Dec 19. pii: S0085-2538(18)30775.
    PubMed     Text format     Abstract available


  49. LIAKOPOULOS V, Eleftheriadis T, Mertens PR
    Screening for renal cell carcinoma in dialysis patients.
    Kidney Int. 2018;94:1238.
    PubMed     Text format    


  50. KRONBICHLER A, Jayne DRW
    ANCA Renal Risk Score: is prediction of end-stage renal disease at baseline possible?
    Kidney Int. 2018;94:1045-1047.
    PubMed     Text format     Abstract available


  51. SAMPATHKUMAR K, Mukuntharajan T, Rajiv A, Anandan S, et al
    Acute page kidney phenomenon following renal allograft biopsy.
    Kidney Int. 2018;94:1241.
    PubMed     Text format    


  52. YEN TH, Wang IK, Hsu CW
    Hemoperfusion for paraquat poisoning.
    Kidney Int. 2018;94:1239.
    PubMed     Text format    


  53. FISCHER RSB, Vangala C, Mandayam S, Chavarria D, et al
    Clinical markers to predict progression from acute to chronic kidney disease in Mesoamerican nephropathy.
    Kidney Int. 2018;94:1205-1216.
    PubMed     Text format     Abstract available


    November 2018
  54. CHARYTAN DM, Himmelfarb J, Ikizler TA, Raj DS, et al
    Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial.
    Kidney Int. 2018 Nov 22. pii: S0085-2538(18)30641.
    PubMed     Text format     Abstract available


  55. KIKUCHI H, Sasaki E, Nomura N, Mori T, et al
    Failure to sense energy depletion may be a novel therapeutic target in chronic kidney disease.
    Kidney Int. 2018 Nov 13. pii: S0085-2538(18)30635.
    PubMed     Text format     Abstract available


  56. BOUCHARA A, Yi D, Pastural M, Granjon S, et al
    Serum levels of the adipokine zinc-alpha2-glycoprotein (ZAG) predict mortality in hemodialysis patients.
    Kidney Int. 2018;94:983-992.
    PubMed     Text format     Abstract available


  57. WANG T, Zhan ZP, Yang L, Lu Y, et al
    Extreme manifestations of hyperparathyroidism in a hemodialysis patient.
    Kidney Int. 2018;94:1028.
    PubMed     Text format    


  58. SCHMITT R
    ZAG-a novel biomarker for cardiovascular risk in ESRD patients?
    Kidney Int. 2018;94:858-860.
    PubMed     Text format     Abstract available


  59. JARDINE AG, Hartmann A, Holdaas H
    Long-term renal allograft survival: a quiet revolution.
    Kidney Int. 2018;94:853-855.
    PubMed     Text format     Abstract available


  60. KRAMER H, Soyibo A, Forrester T, Boyne M, et al
    The burden of chronic kidney disease and its major risk factors in Jamaica.
    Kidney Int. 2018;94:840-842.
    PubMed     Text format    



  61. Grams ME, Sang Y, Ballew SH, et al, for the Chronic Kidney Disease Prognosis Consortium. Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate. Kidney Int. 2018;93:1442-1451.
    Kidney Int. 2018;94:1025-1026.
    PubMed     Text format    


    October 2018
  62. AGARWAL R, Tu W
    Minimally sufficient numbers of measurements for validation of 24-hour blood pressure monitoring in chronic kidney disease.
    Kidney Int. 2018 Oct 23. pii: S0085-2538(18)30608.
    PubMed     Text format     Abstract available


  63. VYCHYTIL A, Herzog R, Probst P, Ribitsch W, et al
    A randomized controlled trial of alanyl-glutamine supplementation in peritoneal dialysis fluid to assess impact on biomarkers of peritoneal health.
    Kidney Int. 2018 Oct 22. pii: S0085-2538(18)30637.
    PubMed     Text format     Abstract available


  64. SANTORIELLO D, Husain SA, De Serres SA, Bomback AS, et al
    Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allografts.
    Kidney Int. 2018 Oct 2. pii: S0085-2538(18)30481.
    PubMed     Text format     Abstract available


  65. KHAN SF, Rosner MH
    "Highlighting" an unusual case of discolored peritoneal dialysis effluent.
    Kidney Int. 2018;94:835.
    PubMed     Text format    


  66. PARFREY PS
    Evocalcet in the management of secondary hyperparathyroidism in dialysis patients.
    Kidney Int. 2018;94:661-662.
    PubMed     Text format     Abstract available


  67. ELEFTHERIADIS T, Pissas G, Liakopoulos V, Stefanidis I, et al
    Xanthine oxidase inhibitors may prevent or slow chronic kidney disease even in the absence of hyperuricemia.
    Kidney Int. 2018;94:830-831.
    PubMed     Text format    


  68. SELISTRE L, Rabilloud M, De Souza V, Iwaz J, et al
    Regarding "Combination of pediatric and adult formulas yield valid glomerular filtration rate estimates in young adults with a history of pediatric chronic kidney disease".
    Kidney Int. 2018;94:827-828.
    PubMed     Text format    


    September 2018
  69. CASPER J, Schmitz J, Brasen JH, Khalifa A, et al
    Renal transplant recipients receiving loop diuretic therapy have increased urinary tract infection rate and altered medullary macrophage polarization marker expression.
    Kidney Int. 2018 Sep 22. pii: S0085-2538(18)30516.
    PubMed     Text format     Abstract available


  70. SHAIKH M, Woodward M, John O, Bassi A, et al
    Utilization, costs, and outcomes for patients receiving publicly funded hemodialysis in India.
    Kidney Int. 2018;94:440-445.
    PubMed     Text format    


    August 2018
  71. BLAKE PG
    Is the peritoneal dialysis biocompatibility hypothesis dead?
    Kidney Int. 2018;94:246-248.
    PubMed     Text format     Abstract available


  72. NIGWEKAR SU, Nazarian RM
    Cutaneous calcification in patients with kidney disease is not always calciphylaxis.
    Kidney Int. 2018;94:244-246.
    PubMed     Text format     Abstract available


    July 2018
  73. JHA V, Modi GK
    Getting to know the enemy better-the global burden of chronic kidney disease.
    Kidney Int. 2018 Jul 24. pii: S0085-2538(18)30362.
    PubMed     Text format     Abstract available


  74. YAMADA S, Leaf EM, Chia JJ, Cox TC, et al
    PiT-2, a type III sodium-dependent phosphate transporter, protects against vascular calcification in mice with chronic kidney disease fed a high-phosphate diet.
    Kidney Int. 2018 Jul 21. pii: S0085-2538(18)30389.
    PubMed     Text format     Abstract available


  75. FUKAGAWA M, Shimazaki R, Akizawa T
    Head-to-head comparison of the new calcimimetic agent evocalcet with cinacalcet in Japanese hemodialysis patients with secondary hyperparathyroidism.
    Kidney Int. 2018 Jul 20. pii: S0085-2538(18)30387.
    PubMed     Text format     Abstract available


  76. XIE Y, Bowe B, Mokdad AH, Xian H, et al
    Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016.
    Kidney Int. 2018 Jul 5. pii: S0085-2538(18)30318.
    PubMed     Text format     Abstract available


  77. TANEMOTO M
    The analysis of hemoglobin A1c in dialysis patients should include the variables that reflect the erythrocyte turnover.
    Kidney Int. 2018;94:220-221.
    PubMed     Text format    


  78. RAYNER HC, Rosansky SJ
    The estimated glomerular filtration rate graph: another tool in the management of patients with advanced chronic kidney disease.
    Kidney Int. 2018;94:222.
    PubMed     Text format    


  79. HAWKINS CL
    Protein carbamylation: a key driver of vascular calcification during chronic kidney disease.
    Kidney Int. 2018;94:12-14.
    PubMed     Text format     Abstract available


    June 2018
  80. WANNER C, Herzog CA, Turakhia MP
    Chronic kidney disease and arrhythmias: highlights from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2018 Jun 20. pii: S0085-2538(18)30358.
    PubMed     Text format    


  81. KARABOYAS A, Xu H, Morgenstern H, Locatelli F, et al
    DOPPS data suggest a possible survival benefit of renin angiotensin-aldosterone system inhibitors and other antihypertensive medications for hemodialysis patients.
    Kidney Int. 2018 Jun 13. pii: S0085-2538(18)30253.
    PubMed     Text format     Abstract available


  82. HU JR, Coresh J, Inker LA, Levey AS, et al
    Serum metabolites are associated with all-cause mortality in chronic kidney disease.
    Kidney Int. 2018 Jun 2. pii: S0085-2538(18)30247.
    PubMed     Text format     Abstract available


  83. LANDWEHR-KENZEL S, Zobel A, Hoffmann H, Landwehr N, et al
    Ex vivo expanded natural regulatory T cells from patients with end-stage renal disease or kidney transplantation are useful for autologous cell therapy.
    Kidney Int. 2018;93:1452-1464.
    PubMed     Text format     Abstract available


  84. WYATT CM, Wanner N
    Gone but not forgotten: resolution of childhood kidney disease and the risk of end-stage kidney disease in adults.
    Kidney Int. 2018;93:1260-1262.
    PubMed     Text format    


  85. QIU C, Hanson RL, Fufaa G, Kobes S, et al
    Cytosine methylation predicts renal function decline in American Indians.
    Kidney Int. 2018;93:1417-1431.
    PubMed     Text format     Abstract available


  86. NADKARNI GN, Chauhan K, Verghese DA, Parikh CR, et al
    Plasma biomarkers are associated with renal outcomes in individuals with APOL1 risk variants.
    Kidney Int. 2018;93:1409-1416.
    PubMed     Text format     Abstract available


    May 2018
  87. RABY AC, Gonzalez-Mateo GT, Williams A, Topley N, et al
    Targeting Toll-like receptors with soluble Toll-like receptor 2 prevents peritoneal dialysis solution-induced fibrosis.
    Kidney Int. 2018 May 31. pii: S0085-2538(18)30254.
    PubMed     Text format     Abstract available


  88. DURLACHER-BETZER K, Hassan A, Levi R, Axelrod J, et al
    Interleukin-6 contributes to the increase in fibroblast growth factor 23 expression in acute and chronic kidney disease.
    Kidney Int. 2018 May 31. pii: S0085-2538(18)30240.
    PubMed     Text format     Abstract available


  89. TAM-THAM H, Quinn RR, Weaver RG, Zhang J, et al
    Survival among older adults with kidney failure is better in the first three years with chronic dialysis treatment than not.
    Kidney Int. 2018 May 23. pii: S0085-2538(18)30246.
    PubMed     Text format     Abstract available


  90. ALEKSOVA J, Wong P, McLachlan R, Choy KW, et al
    Sex hormone-binding globulin is a biomarker associated with nonvertebral fracture in men on dialysis therapy.
    Kidney Int. 2018 May 15. pii: S0085-2538(18)30212.
    PubMed     Text format     Abstract available


  91. SCHAEFER B, Bartosova M, Macher-Goeppinger S, Sallay P, et al
    Neutral pH and low-glucose degradation product dialysis fluids induce major early alterations of the peritoneal membrane in children on peritoneal dialysis.
    Kidney Int. 2018 May 15. pii: S0085-2538(18)30213.
    PubMed     Text format     Abstract available


  92. ALRIC L, Ollivier-Hourmand I, Berard E, Hillaire S, et al
    Grazoprevir plus elbasvir in HCV genotype-1 or -4 infected patients with stage 4/5 severe chronic kidney disease is safe and effective.
    Kidney Int. 2018 May 5. pii: S0085-2538(18)30209.
    PubMed     Text format     Abstract available


  93. NG DK, Schwartz GJ, Schneider MF, Furth SL, et al
    Combination of pediatric and adult formulas yield valid glomerular filtration rate estimates in young adults with a history of pediatric chronic kidney disease.
    Kidney Int. 2018 May 5. pii: S0085-2538(18)30184.
    PubMed     Text format     Abstract available


  94. GOODKIN DA, Bieber B
    International prevalence of hepatitis C positivity among hemodialysis patients awaiting transplantation.
    Kidney Int. 2018;93:1249.
    PubMed     Text format    


  95. FUSARO M, Cannata-Andia JB, Nickolas TL, Plebani M, et al
    Clinical relevance and future perspective of fractures in patients with chronic kidney disease.
    Kidney Int. 2018;93:1248.
    PubMed     Text format    


  96. STENGEL B
    Uncovering real mortality trends in ESRD patients.
    Kidney Int. 2018;93:1040-1043.
    PubMed     Text format     Abstract available


  97. HOMMOS MS, Zeng C, Liu Z, Troost JP, et al
    Global glomerulosclerosis with nephrotic syndrome; the clinical importance of age adjustment.
    Kidney Int. 2018;93:1175-1182.
    PubMed     Text format     Abstract available


    April 2018
  98. NEVEN E, Vervaet B, Brand K, Gottwald-Hostalek U, et al
    Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder.
    Kidney Int. 2018 Apr 28. pii: S0085-2538(18)30174.
    PubMed     Text format     Abstract available


  99. BARUTTA F, Bruno G, Mastrocola R, Bellini S, et al
    The role of cannabinoid signaling in acute and chronic kidney diseases.
    Kidney Int. 2018 Apr 26. pii: S0085-2538(18)30140.
    PubMed     Text format     Abstract available


  100. BRUCK K, Jager KJ, Zoccali C, Bello AK, et al
    Different rates of progression and mortality in patients with chronic kidney disease at outpatient nephrology clinics across Europe.
    Kidney Int. 2018 Apr 12. pii: S0085-2538(18)30096.
    PubMed     Text format     Abstract available


  101. KALRA PA, Green D, Poulikakos D
    Arrhythmia in hemodialysis patients and its relation to sudden death.
    Kidney Int. 2018;93:781-783.
    PubMed     Text format     Abstract available


  102. LABRIOLA L, Jadoul M
    Taurolidine-based lock solutions for hemodialysis catheters: the enthusiasm should be tempered.
    Kidney Int. 2018;93:1015-1016.
    PubMed     Text format    


  103. MATHEW RO, Bangalore S, Sidhu MS, Fleg JL, et al
    Increasing inclusion of patients with advanced chronic kidney disease in cardiovascular clinical trials.
    Kidney Int. 2018;93:787-788.
    PubMed     Text format    


  104. WATERS DD, Vogt L
    Lipids, inflammation, and chronic kidney disease: a SHARP perspective.
    Kidney Int. 2018;93:784-786.
    PubMed     Text format     Abstract available


  105. PRASAD PV
    Update on renal blood oxygenation level-dependent MRI to assess intrarenal oxygenation in chronic kidney disease.
    Kidney Int. 2018;93:778-780.
    PubMed     Text format     Abstract available


  106. GRAUDAL N
    U-shaped dietary sodium-associated incidence of chronic kidney disease cautions against salt overrestriction in hypertension.
    Kidney Int. 2018;93:776-778.
    PubMed     Text format     Abstract available


  107. OOMATIA A, Dupont P, Bass P, Moochhala S, et al
    The Case | Shining a light on an unusual case of chronic kidney disease.
    Kidney Int. 2018;93:1023-1024.
    PubMed     Text format    


  108. VACHHARAJANI TJ, Agarwal AK, Asif A
    Vascular access of last resort.
    Kidney Int. 2018;93:797-802.
    PubMed     Text format     Abstract available


    March 2018
  109. GRAMS ME, Sang Y, Ballew SH, Carrero JJ, et al
    Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate.
    Kidney Int. 2018 Mar 24. pii: S0085-2538(18)30097.
    PubMed     Text format     Abstract available


  110. VERVLOET MG, van Ballegooijen AJ
    Prevention and treatment of hyperphosphatemia in chronic kidney disease.
    Kidney Int. 2018 Mar 23. pii: S0085-2538(18)30124.
    PubMed     Text format     Abstract available


  111. WANG J, Zhang L, Tang SC, Kashihara N, et al
    Disease burden and challenges of chronic kidney disease in North and East Asia.
    Kidney Int. 2018 Mar 21. pii: S0085-2538(18)30094.
    PubMed     Text format    


  112. PUN PH, Wyatt CM
    Utility of implantable cardioverter defibrillators in chronic kidney disease.
    Kidney Int. 2018 Mar 17. pii: S0085-2538(18)30196.
    PubMed     Text format    


  113. BATAL I, Mohan S, De Serres SA, Vasilescu ER, et al
    Analysis of dendritic cells and ischemia-reperfusion changes in postimplantation renal allograft biopsies may serve as predictors of subsequent rejection episodes.
    Kidney Int. 2018 Mar 13. pii: S0085-2538(18)30059.
    PubMed     Text format     Abstract available


  114. TOTH PP, Dwyer JP, Cannon CP, Colhoun HM, et al
    Efficacy and safety of lipid lowering by alirocumab in chronic kidney disease.
    Kidney Int. 2018 Mar 8. pii: S0085-2538(18)30055.
    PubMed     Text format     Abstract available


  115. TONELLI M, Wiebe N, James MT, Klarenbach SW, et al
    A population-based cohort study defines prognoses in severe chronic kidney disease.
    Kidney Int. 2018 Mar 7. pii: S0085-2538(18)30057.
    PubMed     Text format     Abstract available


    February 2018
  116. RABBANI N, Thornalley PJ
    Advanced glycation end products in the pathogenesis of chronic kidney disease.
    Kidney Int. 2018 Feb 22. pii: S0085-2538(18)30051.
    PubMed     Text format     Abstract available


  117. KOPP C, Linz P, Maier C, Wabel P, et al
    Elevated tissue sodium deposition in patients with type 2 diabetes on hemodialysis detected by (23)Na magnetic resonance imaging.
    Kidney Int. 2018 Feb 15. pii: S0085-2538(17)30857.
    PubMed     Text format     Abstract available


  118. SUMIDA K, Molnar MZ, Potukuchi PK, Hassan F, et al
    Treatment of rheumatoid arthritis with biologic agents lowers the risk of incident chronic kidney disease.
    Kidney Int. 2018 Feb 3. pii: S0085-2538(17)30893.
    PubMed     Text format     Abstract available


  119. NITSCH D
    Does dialysis modality affect the development of cognitive impairment?
    Kidney Int. 2018;93:306-308.
    PubMed     Text format     Abstract available


  120. DUSSO A, Colombo MI, Shanahan CM
    Not all vascular smooth muscle cell exosomes calcify equally in chronic kidney disease.
    Kidney Int. 2018;93:298-301.
    PubMed     Text format     Abstract available


  121. ORDUNEZ P, Hoy WE
    Case definitions and approaches for surveillance of chronic kidney disease in agricultural communities in Central America: policy implications.
    Kidney Int. 2018;93:284-287.
    PubMed     Text format    


    January 2018
  122. STOREY BC, Staplin N, Harper CH, Haynes R, et al
    Declining comorbidity-adjusted mortality rates in English patients receiving maintenance renal replacement therapy.
    Kidney Int. 2018 Jan 30. pii: S0085-2538(17)30856.
    PubMed     Text format     Abstract available


  123. ROY-CHAUDHURY P, Tumlin JA, Koplan BA, Costea AI, et al
    Primary outcomes of the Monitoring in Dialysis Study indicate that clinically significant arrhythmias are common in hemodialysis patients and related to dialytic cycle.
    Kidney Int. 2018 Jan 27. pii: S0085-2538(17)30855.
    PubMed     Text format     Abstract available


  124. DOU L, Poitevin S, Sallee M, Addi T, et al
    Aryl hydrocarbon receptor is activated in patients and mice with chronic kidney disease.
    Kidney Int. 2018 Jan 22. pii: S0085-2538(17)30826.
    PubMed     Text format     Abstract available


  125. LIU BC, Tang TT, Lv LL, Lan HY, et al
    Renal tubule injury: a driving force toward chronic kidney disease.
    Kidney Int. 2018 Jan 17. pii: S0085-2538(17)30819.
    PubMed     Text format     Abstract available


  126. PRUIJM M, Milani B, Pivin E, Podhajska A, et al
    Reduced cortical oxygenation predicts a progressive decline of renal function in patients with chronic kidney disease.
    Kidney Int. 2018 Jan 9. pii: S0085-2538(17)30800.
    PubMed     Text format     Abstract available


  127. LEE BJ, Go AS, Parikh R, Leong TK, et al
    Pre-admission proteinuria impacts risk of non-recovery after dialysis-requiring acute kidney injury.
    Kidney Int. 2018 Jan 9. pii: S0085-2538(17)30797.
    PubMed     Text format     Abstract available


  128. BOMBACK AS, Santoriello D, Avasare RS, Regunathan-Shenk R, et al
    C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy.
    Kidney Int. 2018 Jan 6. pii: S0085-2538(17)30802.
    PubMed     Text format     Abstract available


  129. PERSSON F, Borg R
    YKL-40 in dialysis patients: another candidate in the quest for useful biomarkers in nephrology.
    Kidney Int. 2018;93:21-22.
    PubMed     Text format     Abstract available


  130. MARSHALL MR
    Intensive hemodialysis-keeping the faith.
    Kidney Int. 2018;93:10-12.
    PubMed     Text format     Abstract available


  131. RODELO-HAAD C, Aguera ML, Ortega R, Martinez-Lopez A, et al
    Lithium-associated nephropathy in the renal allograft.
    Kidney Int. 2018;93:273.
    PubMed     Text format    


  132. ETTA PK, Rao MV
    Gas in a renal allograft: think beyond!
    Kidney Int. 2018;93:272.
    PubMed     Text format    


  133. FARRAH TE, Anand A, Miller-Hodges E, Mills NL, et al
    Endothelin antagonism reduces circulating galectin-3 in patients with proteinuric chronic kidney disease.
    Kidney Int. 2018;93:270.
    PubMed     Text format    


  134. CHEN Z, Li J, Yang Y, Li H, et al
    The renal artery is involved in Chinese Takayasu's arteritis patients.
    Kidney Int. 2018;93:245-251.
    PubMed     Text format     Abstract available


  135. TENNANKORE KK, Na Y, Wald R, Chan CT, et al
    Short daily-, nocturnal- and conventional-home hemodialysis have similar patient and treatment survival.
    Kidney Int. 2018;93:188-194.
    PubMed     Text format     Abstract available


    December 2017
  136. YU ASL, Shen C, Landsittel DP, Harris PC, et al
    Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease.
    Kidney Int. 2017 Dec 28. pii: S0085-2538(17)30785.
    PubMed     Text format     Abstract available


  137. ANDERS HJ, Suarez-Alvarez B, Grigorescu M, Foresto-Neto O, et al
    The macrophage phenotype and inflammasome component NLRP3 contributes to nephrocalcinosis-related chronic kidney disease independent from IL-1-mediated tissue injury.
    Kidney Int. 2017 Dec 11. pii: S0085-2538(17)30772.
    PubMed     Text format     Abstract available


  138. LI J, Basler M, Alvarez G, Brunner T, et al
    Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantation.
    Kidney Int. 2017 Dec 4. pii: S0085-2538(17)30773.
    PubMed     Text format     Abstract available



  139. Moradi H, Said HM. Functional thiamine deficiency in end-stage renal disease: malnutrition despite ample nutrients. Kidney Int. 2016;90:252-254.
    Kidney Int. 2017;92:1558.
    PubMed     Text format    



  140. Li L, Lai EY, Luo Z, et al. Superoxide and hydrogen peroxide counterregulate myogenic contractions in renal afferent arterioles from a mouse model of chronic kidney disease. Kidney Int. 2017;92:625-633.
    Kidney Int. 2017;92:1558.
    PubMed     Text format    



  141. Ketteler M, Block GA, Evenepoel P, et al. Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters. Kidney Int. 2017;92:26-36.
    Kidney Int. 2017;92:1558.
    PubMed     Text format    


  142. ISAKA Y
    Adaptor protein is a new therapeutic target in chronic kidney disease.
    Kidney Int. 2017;92:1312-1314.
    PubMed     Text format     Abstract available


    November 2017
  143. YOON CY, Noh J, Lee J, Kee YK, et al
    High and low sodium intakes are associated with incident chronic kidney disease in patients with normal renal function and hypertension.
    Kidney Int. 2017 Nov 29. pii: S0085-2538(17)30764.
    PubMed     Text format     Abstract available


  144. WAGENSEIL JE
    Does elastin deficiency cause chronic kidney disease?
    Kidney Int. 2017;92:1036-1038.
    PubMed     Text format     Abstract available


  145. LIN TY, Peng CH, Hung SC, Tarng DC, et al
    Body composition is associated with clinical outcomes in patients with non-dialysis-dependent chronic kidney disease.
    Kidney Int. 2017 Nov 1. pii: S0085-2538(17)30663.
    PubMed     Text format     Abstract available


    October 2017
  146. SAWINSKI D, Forde KA, Locke JE, Cohen JB, et al
    Race but not Hepatitis C co-infection affects survival of HIV+ individuals on dialysis in contemporary practice.
    Kidney Int. 2017 Oct 26. pii: S0085-2538(17)30612.
    PubMed     Text format     Abstract available


  147. NEUMANN D, Mau W, Wienke A, Girndt M, et al
    Peritoneal dialysis is associated with better cognitive function than hemodialysis over a one-year course.
    Kidney Int. 2017 Oct 14. pii: S0085-2538(17)30568.
    PubMed     Text format     Abstract available


  148. CHARYTAN DM, Skali H, Shah NR, Veeranna V, et al
    Coronary flow reserve is predictive of the risk of cardiovascular death regardless of chronic kidney disease stage.
    Kidney Int. 2017 Oct 13. pii: S0085-2538(17)30571.
    PubMed     Text format     Abstract available


  149. TURNER JM, Peixoto AJ
    Blood pressure targets for hemodialysis patients.
    Kidney Int. 2017;92:816-823.
    PubMed     Text format     Abstract available


  150. STREJA E
    Hospital readmission for the dialysis patient: who is (not) responsible?
    Kidney Int. 2017;92:788-790.
    PubMed     Text format     Abstract available


    September 2017
  151. PIMENTEL A, Urena-Torres P, Zillikens MC, Bover J, et al
    Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation.
    Kidney Int. 2017 Sep 27. pii: S0085-2538(17)30567.
    PubMed     Text format     Abstract available


  152. LORENZ G, Schmalenberg M, Kemmner S, Haller B, et al
    Mortality prediction in stable hemodialysis patients is refined by YKL-40, a 40-kDa glycoprotein associated with inflammation.
    Kidney Int. 2017 Sep 20. pii: S0085-2538(17)30540.
    PubMed     Text format     Abstract available


  153. GALVAN DL, Green NH, Danesh FR
    The hallmarks of mitochondrial dysfunction in chronic kidney disease.
    Kidney Int. 2017 Sep 8. pii: S0085-2538(17)30505.
    PubMed     Text format     Abstract available


  154. WINNICKI W, Herkner H, Lorenz M, Handisurya A, et al
    Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters.
    Kidney Int. 2017 Sep 7. pii: S0085-2538(17)30495.
    PubMed     Text format     Abstract available


    July 2017
  155. BROCKLEBANK V, Johnson S, Sheerin TP, Marks SD, et al
    Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland.
    Kidney Int. 2017 Jul 24. pii: S0085-2538(17)30323.
    PubMed     Text format     Abstract available


    April 2017
  156. BIERZYNSKA A, McCarthy HJ, Soderquest K, Sen ES, et al
    Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management.
    Kidney Int. 2017;91:937-947.
    PubMed     Text format     Abstract available


    March 2017
  157. LOWENSTEIN J, Grantham JJ
    Residual renal function: a paradigm shift.
    Kidney Int. 2017;91:561-565.
    PubMed     Text format     Abstract available


  158. RAVINDRAN A, Go RS, Fervenza FC, Sethi S, et al
    Thrombotic microangiopathy associated with monoclonal gammopathy.
    Kidney Int. 2017;91:691-698.
    PubMed     Text format     Abstract available


    February 2017
  159. OELLGAARD J, Gaede P, Rossing P, Persson F, et al
    Intensified multifactorial intervention in type 2 diabetics with microalbuminuria leads to long-term renal benefits.
    Kidney Int. 2017 Feb 7. pii: S0085-2538(16)30747.
    PubMed     Text format     Abstract available


  160. TIMMERMANS SA, Abdul-Hamid MA, Vanderlocht J, Damoiseaux JG, et al
    Patients with hypertension-associated thrombotic microangiopathy may present with complement abnormalities.
    Kidney Int. 2017 Feb 7. pii: S0085-2538(16)30742.
    PubMed     Text format     Abstract available


  161. KU E, Lipkowitz MS, Appel LJ, Parsa A, et al
    Strict blood pressure control associates with decreased mortality risk by APOL1 genotype.
    Kidney Int. 2017;91:443-450.
    PubMed     Text format     Abstract available


    November 2016
  162. READY AR, Nath J, Milford DV, Adu D, et al
    Establishing sustainable kidney transplantation programs in developing world countries: a 10-year experience.
    Kidney Int. 2016;90:916-920.
    PubMed     Text format    


    August 2016
  163. BATAL I, Crew RJ
    The Case | An 80-year-old kidney transplant recipient with malaise and early allograft dysfunction.
    Kidney Int. 2016;90:455-6.
    PubMed     Text format    


    July 2016
  164. WETMORE JB, Guo H, Liu J, Collins AJ, et al
    The incidence, prevalence, and outcomes of glomerulonephritis derived from a large retrospective analysis.
    Kidney Int. 2016 Jul 14. pii: S0085-2538(16)30211.
    PubMed     Text format     Abstract available


    April 2016
  165. GILL J, Dong J, Rose C, Gill JS, et al
    The risk of allograft failure and the survival benefit of kidney transplantation are complicated by delayed graft function.
    Kidney Int. 2016 Apr 5. pii: S0085-2538(16)00324.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Renal Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: